PRA
NVO

Parametric Risk Advisors’s Novo Nordisk NVO Stock Holding History

Parametric Risk Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-38,920
Closed -$1.07M – 121
2015
Q2 		$1.07M Hold
38,920
– – 0.07% 97
2015
Q1 		$1.04M Sell
38,920
-1,080
-3% -$24.9K 0.07% 102
2014
Q4 		$846K Buy
+40,000
New +$893K 0.06% 108

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Parametric Risk Advisors's NVO Position: Q3 2015 in Review

Parametric Risk Advisors sold out of Novo Nordisk (NVO) in Q3 2015, closing a stake of 38,920 shares — an estimated $1.07M sold.

Parametric Risk Advisors first reported a position in NVO in Q4 2014 and held it in 3 quarters. The position peaked at $1.07M in Q2 2015. 525 funds tracked by Wall St. Rank hold NVO as of Q3 2015.

  • Parametric Risk Advisors reported no remaining Novo Nordisk position as of Q3 2015 after selling out during the quarter.
  • Parametric Risk Advisors sold 38,920 Novo Nordisk shares in Q3 2015, an estimated $1.07M.
  • Parametric Risk Advisors first reported a position in Novo Nordisk in Q4 2014 and held it in 3 quarters.
  • Parametric Risk Advisors's Novo Nordisk position peaked at $1.07M in Q2 2015.
  • 525 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2015.

Based on Parametric Risk Advisors's 13F filing for Q3 2015, filed 16 Nov 2015.